Prenatal SSRI alters the hormonal and behavioral responses to stress in female mice: Possible role for glucocorticoid resistance

Hormones and Behavior

Volumn 84, Issue , 2016, Pages 41-49

  Avitsur, Ronit ^a   Grinshpahet, Rachel ^a   Goren, Naama ^a   Weinstein, Ido ^a   Kirshenboim, Or ^a   Chlebowski, Noa ^a  

^a ACADEMIC COLLEGE OF TEL AVIV YAFFO   (Israel)

Author keywords

Fluoxetine; Glucocorticoid resistance; HPA axis; Major depression disorder; Restraint stress; SSRI

Indexed keywords

CORTICOSTERONE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ACUTE STRESS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; ELEVATED PLUS MAZE TEST; FEMALE; FORCED SWIM TEST; GLUCOCORTICOID RESISTANCE; HORMONE RESISTANCE; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; OPEN FIELD TEST; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; BLOOD; CHEMICALLY INDUCED; DEFICIENCY; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INBORN ERROR OF METABOLISM; MENTAL STRESS; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; FEMALE; FLUOXETINE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; METABOLISM, INBORN ERRORS; MICE; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, GLUCOCORTICOID; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL;

EID: 84973480987     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2016.06.001     Document Type: Article

References (80)

1. Alwan S., Reefhuis J., Rasmussen S.A., Friedman J.M. National birth defects prevention study. Patterns of antidepressant medication use among pregnant women in a United States population. J. Clin. Pharmacol. 2011 Feb, 51(2):264-270.
2. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306(5697):879-881.
3. Ansorge M.S., Morelli E., Gingrich J.A. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J. Neurosci. 2008, 28:199-207.
4. Avitsur R., Sheridan J.F. Neonatal stress modulates sickness behavior. Brain Behav. Immun. 2009 Oct, 23(7):977-985. 10.1016/j.bbi.2009.05.056.
5. Avitsur R., Maayan R., Weizman A. Neonatal stress modulates sickness behavior: role for proinflammatory cytokines. J. Neuroimmunol. 2013, 257(1-2):59-66.
6. Avitsur R., Levy S., Goren N., Grinshpahet R. Early adversity, immunity and infectious disease. Stress 2015; Feb 27, 1-8.
7. Avitsur R., Levy S., Grinshpahet R., Goren N., Hirsh O., Zalko A. Prenatal fluoxetine exposure affects cytokine and behavioral response to an immune challenge. J. Neuroimmunol. 2015, 284:49-56. 10.1016/j.jneuroim.2015.05.006.
8. Bairy K.L., Madhyastha S., Ashok K.P., Bairy I., Malini S. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 2007, 79(1):1-11.
9. Barden N., Stec I.S., Montkowski A., Holsboer F., Reul J.M. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology 1997, 66(3):212-220.
10. Bogdanova O.V., Kanekar S., D'Anci K.E., Renshaw P.F. Factors influencing behavior in the forced swim test. Physiol. Behav. 2013 Jun 13, 118:227-239. 10.1016/j.physbeh.2013.05.012.
11. Boulle F., Pawluski J.L., Homberg J.R., Machiels B., Kroeze Y., Kumar N., Steinbusch H.W., Kenis G., Van den Hove D.L. Prenatal stress and early-life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring. Dev. Psychobiol. 2015 Nov 26, 10.1002/dev.21385.
12. Boulle F., Pawluski J.L., Homberg J.R., Machiels B., Kroeze Y., Kumar N., Steinbusch H.W., Kenis G., Van den Hove D.L. Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring. Horm. Behav. 2016 Feb 1, pii: S0018-506X(16)30058-7. 10.1016/j.yhbeh.2016.01.017.
13. Bourke C.H., Stowe Z.N., Neigh G.N., Olson D.E., Owens M.J. Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats. Neurotoxicol. Teratol. 2013 Sep-Oct, 39:100-109. 10.1016/j.ntt.2013.07.008.
14. Brockhurst J., Cheleuitte-Nieves C., Buckmaster C.L., Schatzberg A.F., Lyons D.M. Stress inoculation modeled in mice. Transl. Psychiatry 2015 Mar 31, 5. 10.1038/tp.2015.34.
15. Bromet E., Andrade L.H., Hwang I., Sampson N.A., Alonso J., de Girolamo G., de Graaf R., Demyttenaere K., Hu C., Iwata N., Karam A.N., Kaur J., Kostyuchenko S., Lépine J.P., Levinson D., Matschinger H., Mora M.E., Browne M.O., Posada-Villa J., Viana M.C., Williams D.R., Kessler R.C. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011, 9:90.
16. Cabrera-Vera T.M., Battaglia G. Prenatal exposure to fluoxetine (Prozac) produces site-specific and age-dependent alterations in brain serotonin transporters in rat progeny: evidence from autoradiographic studies. J. Pharmacol. Exp. Ther. 1998, 286(3):1474-1481.
17. Cabrera-Vera T.M., Garcia F., Pinto W., Battaglia G. Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring. J. Pharmacol. Exp. Ther. 1997, 280(1):138-145.
18. Chrousos G.P. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 2009, 5:374-381. 10.1038/nrendo.2009.106.
19. Cole M.A., Kim P.J., Kalman B.A., Spencer R.L. Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies. Psychoneuroendocrinology 2000, 25(2):151-167.
20. da-Silva V.A., SP A., LR M., TG T., CJ L. Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Braz. J. Med. Biol. Res. 1999, 32(1):93-98.
21. Davidson S., Prokonov D., Taler M., Maayan R., Harell D., Gil-Ad I., Weizman A. Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr. Res. 2009, 65(2):236-241.
22. Everds N.E., Snyder P.W., Bailey K.L., Bolon B., Creasy D.M., Foley G.L., Rosol T.J., Sellers T. Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol. Pathol. 2013, 41(4):560-614. 10.1177/0192623312466452.
23. Field T. Prenatal depression effects on early development: a review. Infant Behav. Dev. 2011, 34(1):1-14.
24. Field T., Diego M., Hernandez-Reif M. Prenatal depression effects on the fetus and newborn: a review. Infant Behav. Dev. 2006, 29(3):445-455.
25. Forcelli P.A., Heinrichs S.C. Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking behavior in offspring. Addict. Biol. 2008, 13(1):52-62.
26. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4(12):1002-1012.
27. Gobbi G., Murphy D.L., Lesch K., Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J. Pharmacol. Exp. Ther. 2001, 296:987-995.
28. Goel N., Workman J.L., Lee T.T., Innala L., Viau V. Sex differences in the HPA axis. Compr. Physiol. 2014 Jul, 4(3):1121-1155. 10.1002/cphy.c130054.
29. Golde W.T., Gollobin P., Rodriguez L.L. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab. Anim. (NY) 2005, 34(9):39-43.
30. Harris S.S., Maciag D., Simpson K.L., Lin R.C., Paul I.A. Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat. Brain Res. 2012, 1429:52-60. 10.1016/j.brainres.2011.10.025.
31. Hartley M., Tomlinson M., Greco E., Comulada W.S., Stewart J., le Roux I., Mbewu N., Rotheram-Borus M.J. Depressed mood in pregnancy: prevalence and correlates in two Cape Town peri-urban settlements. Reprod. Health 2011, 8:9.
32. Hayes R.M., Wu P., Shelton R.C., Cooper W.O., Dupont W.D., Mitchel E., Hartert T.V. Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies. Am. J. Obstet. Gynecol. 2012 Jul, 207(1):49. e1-9.
33. Hendrick V., Stowe Z.N., Altshuler L.L., Hwang S., Lee E., Haynes D. Placental passage of antidepressant medications. Am. J. Psychiatry 2003, 160(5):993-996.
34. Hermann G., Tovar C.A., Beck F.M., Sheridan J.F. Kinetics of glucocorticoid response to restraint stress and/or experimental influenza viral infection in two inbred strains of mice. J. Neuroimmunol. 1994 Jan, 49(1-2):25-33.
35. Hilli J., Heikkinen T., Rontu R., Lehtimäki T., Kishida I., Aklillu E., Bertilsson L., Vahlberg T., Laine K. MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs. Eur. Neuropsychopharmacol. 2009, 19(5):363-370.
36. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 1996, 54(1):21-30.
37. Holder M.K., Blaustein J.D. Puberty and adolescence as a time of vulnerability to stressors that alter neurobehavioral processes. Front. Neuroendocrinol. 2014 Jan, 35(1):89-110. 10.1016/j.yfrne.2013.10.004.
38. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23(5):477-501.
39. Homberg J.R., Schubert D., Gaspar P. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol. Sci. 2010, 31(2):60-65.
40. Kino T. Stress, glucocorticoid hormones, and hippocampal neural progenitor cells: implications to mood disorders. Front. Physiol. 2015 Aug 19, 6:230. 10.3389/fphys.2015.00230.
41. Kinsey S.G., Bailey M.T., Sheridan J.F., Padgett D.A., Avitsur R. Repeated social defeat causes increased anxiety-like behavior and alters splenocyte function in C57BL/6 and CD-1 mice. Brain Behav. Immun. 2007 May, 21(4):458-466.
42. Kiryanova V., Dyck R.H. Increased aggression, improved spatial memory, and reduced anxiety-like behaviour in adult male mice exposed to fluoxetine early in life. Dev. Neurosci. 2014, 36(5):396-408. 10.1159/000363102.
43. Knaepen L., Rayen I., Charlier T.D., Fillet M., Houbart V., van Kleef M., Steinbusch H.W., Patijn J., Tibboel D., Joosten E.A., Pawluski J.L. Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague-Dawley rat offspring. PLoS One 2013, 8(2). 10.1371/journal.pone.0057608.
44. Laine K., Heikkinen T., Ekblad U., Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch. Gen. Psychiatry 2003, 60:720-726.
45. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira J., Underwood M.D., Arango V., Kung H.F., Hofer M.A., Hen R., Gingrich J.A. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 2003, 54(10):960-971.
46. Lisboa S.F., Oliveira P.E., Costa L.C., Venâncio E.J., Moreira E.G. Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 2007, 80(1):49-56.
47. McAllister B.B., Kiryanova V., Dyck R.H. Behavioural outcomes of perinatal maternal fluoxetine treatment. Neuroscience 2012, 226:356-366. 10.1016/j.neuroscience.2012.09.024.
48. Meltzer-Brody S. New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum. Dialogues Clin. Neurosci. 2011, 13(1):89-100.
49. Nasreen H.E., Kabir Z.N., Forsell Y., Edhborg M. Prevalence and associated factors of depressive and anxiety symptoms during pregnancy: a population based study in rural Bangladesh. BMC Womens Health 2011, 11:22.
50. Oberlander T.F., Grunau R.E., Fitzgerald C., Papsdorf M., Rurak D., Riggs W. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005, 115(2):411-425.
51. Oberlander T.F., Grunau R., Mayes L., Riggs W., Rurak D., Papsdorf M., Misri S., Weinberg J. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum. Dev. 2008, 84(10):689-697. 10.1016/j.earlhumdev.2008.06.008.
52. Oberlander T.F., Gingrich J.A., Ansorge M.S. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin. Pharmacol. Ther. 2009, 86(6):672-677.
53. Oberlander T.F., Papsdorf M., Brain U.M., Misri S., Ross C., Grunau R.E. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch. Pediatr. Adolesc. Med. 2010, 164(5):444-451.
54. Olivier J.D., Blom T., Arentsen T., Homberg J.R. The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011, 35(6):1400-1408.
55. Olivier J.D., Vallès A., van Heesch F., Afrasiab-Middelman A., Roelofs J.J., Jonkers M., Peeters E.J., Korte-Bouws G.A., Dederen J.P., Kiliaan A.J., Martens G.J., Schubert D., Homberg J.R. Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology 2011, 217(3):419-432.
56. Panagiotakopoulos L., Neigh G.N. Development of the HPA axis: where and when do sex differences manifest?. Front. Neuroendocrinol. 2014 Aug, 35(3):285-302. 10.1016/j.yfrne.2014.03.002.
57. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 2001, 49(5):391-404.
58. Pawluski J.L., Brain U.M., Underhill C.M., Hammond G.L., Oberlander T.F. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function. Psychoneuroendocrinology 2012, 37(7):1019-1028.
59. Pawluski J.L., Rayen I., Niessen N.A., Kristensen S., van Donkelaar E.L., Balthazart J., Steinbusch H.W., Charlier T.D. Developmental fluoxetine exposure differentially alters central and peripheral measures of the HPA system in adolescent male and female offspring. Neuroscience 2012, 220:131-141. 10.1016/j.neuroscience.2012.06.034.
60. Popa D., Léna C., Alexandre C., Adrien J. Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J. Neurosci. 2008, 28(14):3546-3554. 10.1523/JNEUROSCI.4006-07.2008.
61. Porsolt R.D. Animal models of depression: utility for transgenic research. Rev. Neurosci. 2000, 11(1):53-58.
62. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463(1-3):3-33.
63. Quan N., Avitsur R., Stark J.L., He L., Shah M., Caligiuri M., Padgett D.A., Marucha P.T., Sheridan J.F. Social stress increases the susceptibility to endotoxic shock. J. Neuroimmunol. 2001 Apr 2, 115(1-2):36-45.
64. Rayen I., van den Hove D.L., Prickaerts J., Steinbusch H.W., Pawluski J.L. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One 2011, 6(9). 10.1371/journal.pone.0024003.
65. Rayen I., Steinbusch H.W., Charlier T.D., Pawluski J.L. Developmental fluoxetine exposure and prenatal stress alter sexual differentiation of the brain and reproductive behavior in male rat offspring. Psychoneuroendocrinology 2013 Sep, 38(9):1618-1629. 10.1016/j.psyneuen.2013.01.007.
66. Rayen I., Steinbusch H.W., Charlier T.D., Pawluski J.L. Developmental fluoxetine exposure facilitates sexual behavior in female offspring. Psychopharmacology 2014 Jan, 231(1):123-133. 10.1007/s00213-013-3215-5.
67. Rayen I., Gemmel M., Pauley G., Steinbusch H.W., Pawluski J.L. Developmental exposure to SSRIs, in addition to maternal stress, has long-term sex-dependent effects on hippocampal plasticity. Psychopharmacology 2015 Apr, 232(7):1231-1244. 10.1007/s00213-014-3758-0.
68. Reddy M.S. Depression: the disorder and the burden. Indian J. Psychol. Med. 2010, 32(1):1-2.
69. Romero G., Toscano E., Del Río J. Effect of prenatal exposure to antidepressants on 5-HT-stimulated phosphoinositide hydrolysis and 5-HT2 receptors in rat brain. Gen. Pharmacol. 1994 Sep, 25(5):851-856.
70. Russo S.J., Murrough J.W., Han M.H., Charney D.S., Nestler E.J. Neurobiology of resilience. Nat. Neurosci. 2012, 15:1475-1484.
71. Sandström O., Mahdavi J., el-Salhy M. Age-related changes in antral endocrine cells in mice. Histol. Histopathol. 1999 Jan, 14(1):31-36.
72. Seedat S., Scott K.M., Angermeyer M.C., Berglund P., Bromet E.J., Brugha T.S., Demyttenaere K., de Girolamo G., Haro J.M., Jin R., Karam E.G., Kovess-Masfety V., Levinson D., Medina Mora M.E., Ono Y., Ormel J., Pennell B.E., Posada-Villa J., Sampson N.A., Williams D., Kessler R.C. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch. Gen. Psychiatry 2009, 66(7):785-795.
73. Seery M.D., Holman E.A., Silver R.C. Whatever does not kill us: cumulative lifetime adversity, vulnerability, and resilience. J. Pers. Soc. Psychol. 2010, 99:1025-1041.
74. Sheridan J.F., Stark J.L., Avitsur R., Padgett D.A. Social disruption, immunity, and susceptibility to viral infection. Role of glucocorticoid insensitivity and NGF. Ann. N. Y. Acad. Sci. 2000, 917:894-905.
75. Silverman M.N., Pearce B.D., Biron C.A., Miller A.H. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol. 2005, 18(1):41-78.
76. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000 Jun, 24(4):417-463.
77. Svirsky N., Levy S., Avitsur R. Prenatal exposure to selective serotonin reuptake inhibitors (SSRI) increases aggression and modulates maternal behavior in offspring mice. Dev. Psychobiol. 2015 Sep 4, 10.1002/dev.21356.
78. Whitaker-Azmitia P.M., Druse M., Walker P., Lauder J.M. Serotonin as a developmental signal. Behav. Brain Res. 1996, 73:19-29.
79. Yonkers K.A., Wisner K.L., Stewart D.E., Oberlander T.F., Dell D.L., Stotland N., Ramin S., Chaudron L., Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet. Gynecol. 2009, 114(3):703-713.
80. Zohar I., Dosoretz-Abittan L., Shoham S., Weinstock M. Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram. Psychopharmacology 2015 May, 232(9):1643-1653. 10.1007/s00213-014-3803-z.